Professor Qiao Jie: Fertility, IVF, and Reproductive Genetics Specialist
Professor Qiao Jie is a reproductive-medicine specialist, professor, doctoral supervisor, and member of the Chinese Academy of Engineering. She is director of the National Clinical Research Center for Obstetrics and Gynecology and leads research in infertility, assisted reproduction, human gamete and embryo development, preimplantation genetic testing, polycystic ovary syndrome, and reproductive health.
Clinical and Academic Focus
- female and couple infertility;
- in vitro fertilization and intracytoplasmic sperm injection;
- diminished ovarian reserve and advanced reproductive age;
- polycystic ovary syndrome;
- recurrent implantation failure and pregnancy loss;
- preimplantation genetic testing;
- fertility preservation;
- complex reproductive endocrine disorders; and
- second opinions after unsuccessful assisted-reproduction treatment.
Infertility Evaluation
Infertility evaluation should assess both partners when applicable. It may include ovulation, ovarian reserve, uterine and tubal anatomy, semen analysis, endocrine conditions, medical history, age, genetics, and previous pregnancy or treatment outcomes.
Ovarian-reserve tests estimate likely response to stimulation but do not directly measure egg quality or guarantee natural or assisted conception.
In Vitro Fertilization
IVF typically involves ovarian stimulation, egg retrieval, fertilization, embryo culture, and embryo transfer. ICSI may be used for significant male-factor infertility, previous fertilization failure, or selected laboratory indications.
Success depends strongly on age and embryo competence, as well as sperm factors, uterine conditions, laboratory quality, diagnosis, and previous treatment. No clinic can guarantee pregnancy or live birth.
Preimplantation Genetic Testing
Preimplantation genetic testing can examine embryos for a specific monogenic condition, structural chromosome rearrangement, or chromosome-number abnormalities in selected cases.
Testing requires genetic counseling because limitations include embryo mosaicism, sampling error, inconclusive results, possible embryo damage, and the chance that no transferable embryo is identified. Prenatal testing may still be recommended after pregnancy.
Diminished Ovarian Reserve
Diminished ovarian reserve can reduce the number of eggs obtained but does not mean pregnancy is impossible. Treatment may involve individualized stimulation, embryo accumulation in selected cases, donor options where legally available, or alternative family-building plans.
Unproven add-on treatments should be discussed critically, including evidence, cost, risks, and whether they improve live-birth rates.
Polycystic Ovary Syndrome
Polycystic ovary syndrome can involve irregular ovulation, androgen excess, polycystic ovarian appearance, insulin resistance, weight concerns, and increased long-term metabolic risk.
Management depends on goals and can include lifestyle support, ovulation induction, metabolic treatment, cycle protection, acne or hair management, and assisted reproduction. IVF stimulation should minimize ovarian hyperstimulation risk.
Recurrent Implantation Failure
Repeated unsuccessful embryo transfer can result from embryo factors, age, uterine abnormalities, chronic endometrial disease, hydrosalpinx, laboratory variables, or chance. Definitions vary.
Evaluation should be targeted. Broad immune panels and expensive add-ons without strong evidence can lead to unnecessary treatment.
Recurrent Pregnancy Loss
Assessment may include uterine anatomy, parental chromosomes, antiphospholipid syndrome, thyroid disease, diabetes, and genetic testing of pregnancy tissue when available. Many losses are caused by sporadic embryo chromosome abnormalities.
Fertility Preservation
Egg, sperm, embryo, or ovarian-tissue preservation may be considered before gonadotoxic cancer treatment or for selected medical and personal reasons, subject to local regulations. Urgent coordination is important when cancer treatment is time-sensitive.
Who May Consider a Consultation?
- couples or individuals with infertility;
- patients considering IVF or ICSI;
- patients with diminished ovarian reserve or advanced reproductive age;
- patients with PCOS and difficulty conceiving;
- patients with repeated implantation failure or pregnancy loss;
- families considering preimplantation genetic testing;
- patients seeking fertility preservation before medical treatment; or
- patients seeking a second opinion after unsuccessful IVF cycles.
Medical Records to Prepare
- a concise fertility, pregnancy, and treatment timeline;
- menstrual-cycle and ovulation records;
- AMH, FSH, LH, estradiol, thyroid, prolactin, glucose, and metabolic results;
- pelvic ultrasound, tubal testing, hysteroscopy, and uterine imaging;
- semen analyses and male-fertility assessments;
- all stimulation protocols, follicle monitoring, and egg-retrieval reports;
- fertilization, embryo-development, grading, transfer, and cryostorage records;
- genetic, PGT, miscarriage-tissue, and pathology reports;
- a complete medication and supplement list; and
- a clear list of reproductive goals and time constraints.
Planning an International Consultation
Severe pain, heavy bleeding, fainting, fever, breathing difficulty, or rapid abdominal swelling during fertility treatment requires urgent local assessment.
Stable patients should confirm whether complete embryology and genetic records can be reviewed. Remote medical-record review requires physician authorization. Final IVF, PGT, preservation, or transfer eligibility requires in-person assessment and compliance with current Chinese laws, hospital policy, and laboratory criteria.
How CMCS Can Assist
CMCS – China Medical Concierge Shanghai is an independent medical concierge and health management company, not a hospital. We assist international patients with organizing and translating fertility records, identifying an appropriate specialist, requesting appointment availability, arranging interpretation, and planning medical travel in China.
Access to Professor Qiao, remote review, IVF, PGT, fertility preservation, or a particular laboratory service is subject to doctor, hospital, legal, and eligibility requirements. CMCS does not guarantee appointments, embryo availability, pregnancy, live birth, or clinical outcomes.
- Email: contract@medicalsh.com
- WhatsApp: Contact us on WhatsApp
- Website: www.medicalsh.com
Important Note
Doctor titles, clinical roles, laws, laboratory services, medicines, procedures, and appointment arrangements may change. This profile is based on the supplied verified research document and is for general information only. It does not replace assessment by a qualified reproductive-medicine team.
0 則留言